Lanxess (LXS) Q1 2026 (Media) earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 (Media) earnings summary
7 May, 2026Executive summary
Q1 2026 sales declined 13.9% year-over-year to €1,378 million, mainly due to weak demand, negative currency effects, and the sale of the Urethane Systems business unit.
EBITDA pre exceptionals fell 29.3% to €94 million, with margin dropping to 6.8% from 8.3% year-over-year, reflecting weak demand, lower selling prices, and negative currency impacts.
Net income was negative at €141 million, compared to negative €57 million in Q1 2025.
Positive momentum emerged in March, driven by supply chain disruptions in Asia and increased customer demand for European suppliers, with improved volumes and momentum continuing into Q2.
Full-year 2026 EBITDA guidance of €450–550 million is confirmed, with cost discipline and expectations for improvement in the second half.
Financial highlights
Q1 2026 group sales were €1,378 million, down 14% year-over-year, and EBITDA pre exceptionals dropped 29% to €94 million.
Gross profit declined to €262 million from €322 million year-over-year.
EBITDA margin pre exceptionals decreased to 6.8% from 8.3% in Q1 2025.
Cash flow from operating activities improved to €12 million from minus €66 million, and free cash flow improved to minus €29 million from minus €111 million.
Net financial liabilities increased to €2,085 million as of March 31, 2026.
Outlook and guidance
Full-year 2026 EBITDA pre exceptionals guidance is reaffirmed at €450–550 million.
Q2 2026 EBITDA pre exceptionals is expected to rise significantly to €130–150 million.
Positive momentum is expected to continue in Q2 and the second half, with price increases implemented in April and May.
Effects from the German economic stimulus program are anticipated in H2 2026 or early 2027.
Market conditions are expected to remain challenging, with persistent negative FX impact from a weak US dollar.
Latest events from Lanxess
- Sales and EBITDA dropped, but full-year guidance is confirmed and Q2 is set to improve.LXS
Q1 20267 May 2026 - Revenue and earnings declined, but debt reduction and cost cuts support a late 2026 recovery.LXS
Q4 2025 (Media)1 May 2026 - 2026 EBITDA guidance is €450–550 million, with recovery expected in H2 2026.LXS
Q4 202519 Mar 2026 - Earnings rose, costs fell, and sustainability advanced amid global uncertainty and strategic refocus.LXS
AGM 20253 Feb 2026 - Q2 2024 EBITDA pre exceptionals surged 69% year-over-year despite lower sales.LXS
Q2 20241 Feb 2026 - EBITDA pre exceptionals jumped 45% and net income returned to profit in Q3 2024.LXS
Q3 202416 Jan 2026 - EBITDA rose 20% in 2024 as cost savings and portfolio focus drove profitability gains.LXS
Q4 202426 Dec 2025 - Q2 sales and EBITDA fell on weak demand, but net debt dropped after Urethane divestment.LXS
Q2 202523 Nov 2025 - EBITDA pre up 32% to €133m; guidance held as Urethane sale supports debt reduction.LXS
Q1 202517 Nov 2025